Table 3.
Characteristic | Neck | Upper mediastinum | Abdomen | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariable | Univariable | Multivariable | Univariable | Multivariable | ||||||
HR | 95%CI | HR | 95%CI | exp(B) | 95%CI | HR | 95%CI | exp(B) | 95%CI | |
Age (≥ 60 v < 60) |
0.64 | 0.26–1.55 | 1.02 | 0.47–2.23 | – | – | 0.47 | 0.21–1.06 | – | – |
Sex (male v female) |
2.48 | 0.75–7.98 | 0.56 | 0.15–2.16 | – | – | 2.10 | 0.69–6.43 | – | – |
T stage (T1–2 v T3–4) |
0.45 | 0.18–1.17 | 0.68 | 0.29–1.60 | – | – | 2.92 | 0.94–9.11 | – | – |
N stage (N0 v N1–3) |
2.80 | 0.89–8.82 | 1.42 | 0.61–3.31 | – | – | 2.11 | 0.83–5.36 | – | – |
TNM stage (II v III + IV) |
2.52 | 0.92–6.86 | 1.01 | 0.49–2.33 | – | – | 2.87 | 1.76–7.01 | – | – |
Length (≥ 4 cm v < 4 cm) |
1.10 | 0.44–2.75 | 0.93 | 0.43–2.04 | – | – | 0.84 | 0.38–1.89 | – | – |
Tumour emboli (yes v no) |
0.76 | 0.16–3.68 | 1.60 | 0.49–5.26 | – | – | 1.30 | 0.37–4.55 | – | – |
CT (yes v no) |
1.27 | 0.52–3.12 | 1.20 | 0.56–2.60 | – | – | 1.25 | 0.56–2.77 | – | – |
RT (yes v no) |
0.69 | 0.28–1.68 | 0.32 | 0.15–0.71 | 0.30 | 0.13–0.68 | 0.36 | 0.16–0.83 | 0.37 | 0.16–0.85 |
Positive LN in | ||||||||||
UM (yes v no) |
1.17 | 0.35–3.92 | 3.33 | 1.23–9.06 | 3.72 | 1.30–10.67 | 0.73 | 0.22–2.37 | – | – |
LM (yes v no) |
2.97 | 1.19–7.39 | 1.24 | 0.56–2.71 | – | – | 0.67 | 0.29–1.57 | – | – |
Abdomen (yes v no) |
0.92 | 0.37–2.66 | 1.00 | 0.46–2.16 | – | – | 2.59 | 1.15–5.85 | 2.57 | 1.12–5.92 |
CT chemotherapy, RT radiotherapy, LN lymph node, UM upper mediastinum, LM lower mediastinum
There were statistically significant differences for data in Italics (p < 0.05)